文献速递母胎医学

超声表型分析在FGFR3相关骨骼发育不良无创产前诊断中的作用

The role of sonographic phenotyping in delivering an efficient noninvasive prenatal diagnosis service for FGFR3-related skeletal dysplasias.
PubMed 文献 · Prenat Diagn · 2020-05-25

该研究回顾2012至2018年实验室与转诊记录,评估基于下一代测序panel检测FGFR3突变的NIPD诊断率,并分析超声表型与转诊准确性的关系。335例检测中261例因超声发现转诊,其中80例(31.3%)检出突变;仅短肢时诊断率17.9%(30/168),合并一个特征时48.9%(23/47),合并两个及以上特征时82.6%(19/23)。结论认为准确超声表型分析可最大化NIPD诊断率,建议制定明确转诊指南。

要点

  • 仅短肢异常时FGFR3突变NIPD诊断率为17.9%(30/168)。
  • 短肢合并一个特征时诊断率升至48.9%(23/47),合并两个及以上特征达82.6%(19/23)。
  • 准确超声表型分析有助于提高NIPD诊断效率并减少不必要检测。

核心结论

  • 准确超声表型分析可最大化疑似FGFR3相关骨骼发育不良胎儿的NIPD诊断率。
  • 建议制定明确转诊指南以提高收益、降低成本并避免不必要的NIPD。

研究设计与样本

  • 回顾性研究,分析2012至2018年实验室与转诊记录中所有使用下一代测序panel检测FGFR3突变的NIPD检测。
  • 共335例检测,其中261例因超声发现转诊。

主要发现

  • 335例检测中261例因超声发现转诊,80例(31.3%)检出突变。
  • 仅短肢为唯一异常超声特征时诊断率为17.9%(30/168)。
  • 短肢合并一个特征时诊断率为48.9%(23/47),合并两个及以上特征时为82.6%(19/23)。

临床怎么用

  • 转诊前应详细评估超声表型,短肢合并特征数量越多,FGFR3突变NIPD诊断率越高。
  • 依据超声表型选择转诊可避免不必要的NIPD检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the diagnostic yield of noninvasive prenatal diagnosis (NIPD) for FGFR3-related skeletal dysplasias and assess the accuracy of referrals based on sonographic findings to inform guidelines for referral. METHODS: We retrospectively reviewed laboratory and referral records from 2012 to 2018 to ascertain all NIPD tests performed using our next generation sequencing panel to detect FGFR3 mutations. We calculated the diagnostic yield of the test overall and when sub-divided according to the phenotypic features identified on ultrasound before testing. Pregnancy outcomes were ascertained wherever possible from referring centers. RESULTS: Of 335 tests, 261 were referred because of sonographic findings, of which 80 (31.3%) had a mutation. The diagnostic yield when short limbs were the only abnormal sonographic feature reported was 17.9% (30/168), increasing to 48.9% (23/47) in the presence of one, and 82.6% (19/23) in the presence of two or more characteristic features in addition to short limbs. CONCLUSIONS: Accurate sonographic phenotyping can maximise the diagnostic yield of NIPD in fetuses suspected to have FGFR3-related skeletal dysplasias. We suggest that clear guidelines for referral are necessary to increase benefits, decrease costs by preventing unnecessary NIPD, and potentially allow first-line broader spectrum testing for fetuses where the aetiology may be more heterogeneous.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Mellis R, Chandler N, Jenkins L, et al. The role of sonographic phenotyping in delivering an efficient noninvasive prenatal diagnosis service for FGFR3-related skeletal dysplasias. Prenat Diagn. 2020. PMID: 32227640. doi:10.1002/pd.5687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。